Long-Term Outcomes and Durability of Effect Following Treatment With Cladribine Tablets for MS (CLASSIC-MS)

Clinical trial NCT03961204 · COMPLETED

Trial details

NCT number: NCT03961204
Sponsor: EMD Serono Research & Development Institute, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis (MS)

Start date: 2019-08-15
Primary completion: 2021-02-27
Enrollment: 662

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.